ChemoCentryx Receives FDA Orphan Products Development Grant for CCX168 as Treatment for ANCA-Associated … – Sonoran Weekly Review

ChemoCentryx Receives FDA Orphan Products Development Grant for CCX168 as Treatment for ANCA-Associated … – Sonoran Weekly Review

ChemoCentryx Receives FDA Orphan Products Development Grant for CCX168 as Treatment for ANCA-Associated … – Sonoran Weekly Review
Published on 2016-04-29